Dr. Schaar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-2465Fax+1 732-212-0713
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 1999 - 2003
- University of MarylandResidency, Internal Medicine, 1997 - 1999
- Rutgers Robert Wood Johnson Medical SchoolClass of 1997
- University of Medicine and Dentistry of New Jersey/Rutgers UniversityPh.D., Microbiology (joint degree), 1991
- Cook College, Rutgers UniversityB.A., Biochemistry, 1984
Certifications & Licensure
- NJ State Medical License 1999 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Amgen Oncology Fellowship 2000
- Predoctoral Fellowship New Jersey Commission on Cancer Research, 1988
Clinical Trials
Publications & Presentations
PubMed
- 38 citationsMultiple Astrocyte Transcripts Encode Nigral Trophic Factors in Rat and HumanDale G. Schaar, Beth-Anne Sieber, Ann C. Sherwood, Deyrick O. Dean, Grace Mendoza
Experimental Neurology. 1994-12-01 - 8 citationsCheckpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.Andrew M Evens, Justin S Brandt, Cody J Peer, Tyler Yin, Dale Schaar
American Journal of Hematology. 2022-06-01 - 46 citationsLactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic st...Elan Gorshein, Catherine Wei, Susan Ambrosy, Shanna Budney, Juliana Vivas
Clinical Transplantation. 2017-05-01
Journal Articles
- PDCD2 functions in cancer cell proliferation and predicts relapsed leukemiaBarboza, N., Minakhina, S., Medina, D.J., Balsara, B., Greenwood, S., Huzzy, L., Rabson, A.B., Steward, R. and Schaar, D.G., Cancer Biol Ther, 6/1/2013
- A Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic SyndromeRaza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF, Sekeres M, Cancer, 4/1/2012
- Accelerated R-COP: A Pilot study for the treatment of advanced low grade lymphomas that has a high complete response rateLevitt, M.J., Gharibo, M., Strair, R., Schaar, D., Rubin, A. and Bertino, J.R., J Chemotherapy, 1/1/2009
- Join now to see all
Abstracts/Posters
- Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...Dale Schaar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Dual-Specificity MAPK Phosphatases (DS-MKPs): novel targets for AML therapy.Schaar, D.G., Ting, Y. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2006
- Novel Strategies Targeting Pro-Survival Pathways in AML.Schaar, D.G., Liu, H., Sharma, S., Ting, Y., Martin, J., Krier, C., Ciardella, M., Osman, M., Goodell, L., Notterman, D.A. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2005
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: